BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31850240)

  • 1. Serotyping of
    Arranz-Solís D; Cordeiro C; Young LH; Dardé ML; Commodaro AG; Grigg ME; Saeij JPJ
    Front Cell Infect Microbiol; 2019; 9():408. PubMed ID: 31850240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing New Peptides From
    Xicoténcatl-García L; Enriquez-Flores S; Correa D
    Front Cell Infect Microbiol; 2019; 9():368. PubMed ID: 31709197
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides.
    Kong JT; Grigg ME; Uyetake L; Parmley S; Boothroyd JC
    J Infect Dis; 2003 May; 187(9):1484-95. PubMed ID: 12717631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping.
    Sousa S; Ajzenberg D; Marle M; Aubert D; Villena I; da Costa JC; Dardé ML
    Clin Vaccine Immunol; 2009 Aug; 16(8):1158-69. PubMed ID: 19494084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Toxoplasma gondii GRA15 peptides in diagnosis and serotyping.
    Li R; Ma Y; Li J; Zhou P; Zheng F; Liu Q; Gao W
    Microb Pathog; 2020 Jun; 143():104168. PubMed ID: 32205209
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Arranz-Solís D; Carvalheiro CG; Zhang ER; Grigg ME; Saeij JPJ
    Front Cell Infect Microbiol; 2021; 11():621738. PubMed ID: 33680990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America).
    Peyron F; Lobry JR; Musset K; Ferrandiz J; Gomez-Marin JE; Petersen E; Meroni V; Rausher B; Mercier C; Picot S; Cesbron-Delauw MF
    Microbes Infect; 2006 Aug; 8(9-10):2333-40. PubMed ID: 16938480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents.
    Sousa S; Ajzenberg D; Vilanova M; Costa J; Dardé ML
    Clin Vaccine Immunol; 2008 Sep; 15(9):1380-6. PubMed ID: 18667636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray.
    Maksimov P; Zerweck J; Maksimov A; Hotop A; Gross U; Spekker K; Däubener W; Werdermann S; Niederstrasser O; Petri E; Mertens M; Ulrich RG; Conraths FJ; Schares G
    PLoS One; 2012; 7(3):e34212. PubMed ID: 22470537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide microarray analysis of in silico-predicted epitopes for serological diagnosis of Toxoplasma gondii infection in humans.
    Maksimov P; Zerweck J; Maksimov A; Hotop A; Gross U; Pleyer U; Spekker K; Däubener W; Werdermann S; Niederstrasser O; Petri E; Mertens M; Ulrich RG; Conraths FJ; Schares G
    Clin Vaccine Immunol; 2012 Jun; 19(6):865-74. PubMed ID: 22496494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
    Bastos LM; Macêdo AG; Silva MV; Santiago FM; Ramos EL; Santos FA; Pirovani CP; Goulart LR; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():59. PubMed ID: 27313992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotyping of naturally Toxoplasma gondii infected meat-producing animals.
    Sousa S; Canada N; Correia da Costa JM; Dardé ML
    Vet Parasitol; 2010 Apr; 169(1-2):24-8. PubMed ID: 20083355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis.
    Nowakowska D; Colón I; Remington JS; Grigg M; Golab E; Wilczynski J; Sibley LD
    J Clin Microbiol; 2006 Apr; 44(4):1382-9. PubMed ID: 16597866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of GRA3, GRA6 and GRA7 peptides offer a useful tool for serotyping type II and III
    Arranz-Solís D; Tana LR; Tejerina-de-Uribe E; López-Ureña NM; Koudela B; Francia ME; Ortega-Mora LM; Álvarez-García G
    Front Cell Infect Microbiol; 2024; 14():1384393. PubMed ID: 38720960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new serotyping ELISA for Toxoplasma gondii type II, type III and Africa 1 lineages using in silico peptide discovery methods, well categorized feline and human outbreak serum samples.
    Can H; Aksoy Gökmen A; Döşkaya M; Erkunt Alak S; Değirmenci Döşkaya A; Karakavuk M; Köseoğlu AE; Karakavuk T; Gül C; Güvendi M; Gül A; Gürüz AY; Kaya S; Mercier A; Ün C
    BMC Infect Dis; 2022 Jan; 22(1):110. PubMed ID: 35100997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.
    Xiao J; Buka SL; Cannon TD; Suzuki Y; Viscidi RP; Torrey EF; Yolken RH
    Microbes Infect; 2009 Nov; 11(13):1011-8. PubMed ID: 19638313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation.
    Jensen KD; Wang Y; Wojno ED; Shastri AJ; Hu K; Cornel L; Boedec E; Ong YC; Chien YH; Hunter CA; Boothroyd JC; Saeij JP
    Cell Host Microbe; 2011 Jun; 9(6):472-83. PubMed ID: 21669396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America.
    Morisset S; Peyron F; Lobry JR; Garweg J; Ferrandiz J; Musset K; Gomez-Marin JE; de la Torre A; Demar M; Carme B; Mercier C; Garin JF; Cesbron-Delauw MF
    Microbes Infect; 2008 Jun; 10(7):742-7. PubMed ID: 18539501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: A review.
    Javadi Mamaghani A; Fathollahi A; Spotin A; Ranjbar MM; Barati M; Aghamolaie S; Karimi M; Taghipour N; Ashrafi M; Tabaei SJS
    Microb Pathog; 2019 Dec; 137():103788. PubMed ID: 31605758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C57BL/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues.
    Barros HLS; Santana SS; Pajuaba ACAM; da Silva Cardoso Barros P; Dos Reis de Carvalho F; de Paiva VF; Wilson Patriarca Mineo T; Mineo JR
    Acta Trop; 2019 Aug; 196():1-6. PubMed ID: 31059707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.